BEST OF 2005: RUNNERS-UP

GLUCOSE CONTROL

Amylin's Byetta for type 2 diabetes

Patients with diabetes have a new ally: the gila monster. A hormone from that lizard's spit has been turned into a new treatment by Amylin Pharmaceuticals and Eli Lilly. The injectable drug is a superpotent version of a natural human hormone that regulates insulin, which in turn controls blood sugar. It's $2,700-per-year, but most of that will be covered by insurance (800 868-1190, byetta.com).

Read the story

Slide Show: Best Ideas

Slide Show: Best Leaders

More Slide Shows